journal article·2025-01Open access

Molecular Programming Design of Glyconucleic Acid Aptamer with High Stability

Yongqi Han, Rongjun Zhang, Hong‐Liang Bao, Mei Yang, Yuan Gao, Xiaobo Gao, Ruowen Wang, Weihong Tan, Ding‐Kun Ji

Advanced Science· Volume 12· Issue 4

Abstract

Abstract Functional nucleic acids (FNAs), possessing specific biological functions beyond their informational roles, have gained widespread attention in disease therapeutics. However, their clinical application is severely limited by their low serum stability in complex physiological environments. In this work, a precise molecular programming strategy is explored to prepare glyconucleic acid aptamers (GNAAs) with high serum stability. Four glyconucleic acid modules compatible with commercial solid‐phase synthesis are designed and synthesized. Through precise molecular design, the accurate modification of four different carbohydrate ligands at specific sites of DNA aptamers is achieved. It is demonstrated that glycosylation modification can significantly increase DNA aptamers’ serum stability while maintaining their structures and high affinity. The stabilization effect is superior to that of currently commonly used commercial chemical modifications. Moreover, it is confirmed that this approach displays insignificant effects on the DNA aptamers’ tumor‐targeting ability and metabolism in vivo. This method offers a simple, economical, and efficient strategy for precise glycosylation modification of nucleic acids. This allows to prepare glycosyl functional nucleic acids with high serum stability, which can expand the application scope of functional nucleic acids and promote the practical transformation of functional nucleic acids.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery · DNA and Nucleic Acid Chemistry

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Molecular Medicine (IMM) Renji Hospital State Key Laboratory of Oncogenes and Related Genes Shanghai Jiao Tong University School of Medicine Shanghai 200240 China

College of Chemistry and Materials Science Shanghai Normal University Shanghai 200234 China

Department of Anatomy and Physiology Shanghai Jiao Tong University School of Medicine Shanghai 200025 China

Zhejiang Cancer Hospital Hangzhou Institute of Medicine (HIM) The Chinese Academy of Sciences Hangzhou Zhejiang 310022 China

Molecular Science and Biomedicine Laboratory (MBL) State Key Laboratory of Chemo/Biosensing and Chemometrics College of Chemistry and Chemical Engineering College of Biology Aptamer Engineering Center of Hunan Province Hunan University Changsha Hunan 410082 China

Funding

National Natural Science Foundation of China · Fundamental Research Funds for the Central Universities · Natural Science Foundation of Shanghai Municipality

References (36)

Show source-provided references
1. 10.1038/s41565-021-00898-010.1038/s41565-021-00898-0 ↗
2. 10.1038/s41576-021-00439-410.1038/s41576-021-00439-4 ↗
3. 10.1038/s41573-020-0075-710.1038/s41573-020-0075-7 ↗
4. 10.1038/nrneurol.2017.14810.1038/nrneurol.2017.148 ↗
5. 10.1038/nbt.376510.1038/nbt.3765 ↗
6. 10.1038/nrd.2017.24310.1038/nrd.2017.243 ↗
7. 10.1038/nrd.2016.19910.1038/nrd.2016.199 ↗
8. 10.1021/jacs.3c0084110.1021/jacs.3c00841 ↗
9. 10.1021/jacs.9b1051010.1021/jacs.9b10510 ↗
10. 10.1021/jacs.1c0301310.1021/jacs.1c03013 ↗
11. 10.31635/ccschem.023.20230316110.31635/ccschem.023.202303161 ↗
12. 10.1016/j.addr.2018.08.00510.1016/j.addr.2018.08.005 ↗
13. 10.1016/j.biomaterials.2018.08.02110.1016/j.biomaterials.2018.08.021 ↗
14. 10.1021/acsami.0c0575010.1021/acsami.0c05750 ↗
15. 10.1002/anie.20090145210.1002/anie.200901452 ↗
16. 10.1039/c3tb20412j10.1039/c3tb20412j ↗
17. 10.1002/anie.20180415610.1002/anie.201804156 ↗
18. 10.1016/j.carbon.2023.11836910.1016/j.carbon.2023.118369 ↗
19. 10.1021/acsnano.1c0526510.1021/acsnano.1c05265 ↗
20. 10.1021/nn507494p10.1021/nn507494p ↗
21. 10.1002/cbic.20080049110.1002/cbic.200800491 ↗
22. 10.1016/j.cell.2021.04.02310.1016/j.cell.2021.04.023 ↗
23. 10.1016/j.cell.2021.05.02510.1016/j.cell.2021.05.025 ↗
24. R. A.Flynn B.Goodman C.Lawlor N.Bisaria R.Cummings M.Wei C. R.Bertozzi 2024 US 2024/0261420 A1.
25. 10.1039/D2CS00788F10.1039/D2CS00788F ↗
26. 10.1016/j.bmcl.2015.08.01910.1016/j.bmcl.2015.08.019 ↗
27. 10.1002/cbic.20150002310.1002/cbic.201500023 ↗
28. 10.1016/j.bmc.2015.11.03610.1016/j.bmc.2015.11.036 ↗
29. 10.1002/anie.20221810610.1002/anie.202218106 ↗
30. 10.1073/pnas.060261510310.1073/pnas.0602615103 ↗
31. 10.1038/nrd314110.1038/nrd3141 ↗
32. 10.1002/med.2146210.1002/med.21462 ↗
33. 10.1021/jacs.9b0372010.1021/jacs.9b03720 ↗
34. 10.1038/s43586-023-00199-x10.1038/s43586-023-00199-x ↗
35. 10.1002/EXP.2021009910.1002/EXP.20210099 ↗
36. 10.1073/pnas.240406012110.1073/pnas.2404060121 ↗